JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01877 JUNSHI BIO

Trading 07-09 10:09:33

18.790

+0.290

+1.57%

High19.320	Low18.080	Vol1.06M
Open18.850	D1 Closing18.500	Amplitude6.70%
Mkt Cap19.30B	Tradable Cap4.89B	Total Shares1.03B
T/O19.94M	T/O Rate0.41%	Tradable Shares260.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"JUNSHI BIO","latestPrice":18.79,"timestamp":1783562953446,"preClose":18.5,"halted":0,"volume":1059800,"delay":0,"changeRate":0.01567567567567563,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"Trading","change":0.29,"latestTime":"07-09 10:09:33","open":18.85,"high":19.32,"low":18.08,"amount":19939784,"amplitude":0.067027,"askPrice":18.85,"askSize":1200,"bidPrice":18.79,"bidSize":5400,"shortable":3,"etf":0,"ttmEps":-0.691,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1783569600000},"marketStatusCode":2,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":18.5,"openAndCloseTimeList":[[1783560600000,1783569600000],[1783573200000,1783584000000]],"volumeRatio":1.432577,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"Shanghai Junshi Biosciences Co.,Ltd.","latestPrice":36.26,"timestamp":1783562970000,"preClose":35.9,"halted":0,"volume":7608700,"delay":0,"premium":"-55.04"}},"requestUrl":"/m/hq/s/01877/tweets","defaultTab":"tweets","newsList":[{"id":"1191400913","title":"Junshi Biosciences to Seek H-Share Repurchase Mandate at 27 July 2026 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1191400913","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191400913?lang=en_us&edition=fundamental","pubTime":"2026-07-08 22:24","pubTimestamp":1783520665,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156374670","title":"Junshi Biosciences Sets 22–27 July 2026 H-Share Register Closure to Confirm First EGM Entitlements","url":"https://stock-news.laohu8.com/highlight/detail?id=1156374670","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156374670?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:05","pubTimestamp":1783515917,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. has scheduled a suspension of H-share transfers from Wednesday, 22 July 2026 to Monday, 27 July 2026, both dates inclusive. The temporary closure will allow the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649690608","title":"Possible Turnaround For Shanghai Junshi Biosciences Insiders, Still Down CN¥4.6m","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690608","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690608?lang=en_us&edition=fundamental","pubTime":"2026-07-05 09:44","pubTimestamp":1783215847,"startTime":"0","endTime":"0","summary":"Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. ( HKG:1877 ) stock in the last year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1877/shanghai-junshi-biosciences-shares/news/possible-turnaround-for-shanghai-junshi-biosciences-insiders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","BK1583","CN","01877","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166669760","title":"Junshi Bio June 2026 Monthly Return: Share Capital Unchanged, 37.91 Million Options Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1166669760","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166669760?lang=en_us&edition=fundamental","pubTime":"2026-07-03 16:43","pubTimestamp":1783068201,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648288575","title":"Shanghai Junshi Biosciences HK Shares Hit 4-week Peak on Fosun's Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2648288575","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648288575?lang=en_us&edition=fundamental","pubTime":"2026-07-02 11:27","pubTimestamp":1782962830,"startTime":"0","endTime":"0","summary":"BUZZ-Shanghai Junshi Biosciences HK shares hit 4-week peak on Fosun's licensing deal** Hong Kong shares of Shanghai Junshi Biosciences1877.HKjump 14.5% to HK$19.06, their highest level since June 2** ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL1N43402G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688180","00656","BK0187","BK1230","BK0028","BK0196","BK1593","02196","01877","BK0175","BK0188","BK1191","BK1515","BK1583","BK0183","600196","BK0012","BK0060","BK0096","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108387678","title":"JUNSHI BIO Shares Surge Over 11% on Licensing Agreement for Novel Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1108387678","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108387678?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:30","pubTimestamp":1782955831,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (HKG: 01877) shares opened sharply higher, gaining more than 11%. At the time of writing, the stock is up 11.11% to HK$18.5, with a turnover of HK$1.6724 million. The significant move...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","BK1583","BK4585","BK1515","01877","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102844707","title":"Junshi Biosciences licenses anti-IL-17A antibody “Roconkibart” to Fosun Wanbang in RMB1.34 billion deal for Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=1102844707","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102844707?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:43","pubTimestamp":1782906226,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”) has signed an exclusive licensing agreement with Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd., a wholly owned subsidiary of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648510555","title":"Shanghai Junshi Biosciences - Will Grant Fosun Wanbang Right to Develop, Others, Roconkibart (\"js005\") in Greater China Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2648510555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648510555?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:37","pubTimestamp":1782905846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN43302B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688180","BK1161","BK1583","01877","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","LU2328871848.SGD","86618","BK1583","XLV","BK0239","00241","01093","LU1807302812.USD","LU1808992512.USD","BK0216","BK1502","01877","LU1226287529.USD","LU2039709279.SGD","LU1303224171.USD","BK1191","BK0028","02315","BK4585","XBI","600276","ISBC","BK4137","BK0196","LU0140636845.USD","ONC","LU1008478684.HKD","LABU","ARTY","HCSG","688180","603259","LU0315179316.USD","AIPO","BK0012","LU0456827905.SGD","09637","BK1161","BK1189","IE00BZ08YS42.EUR","AGIX","01801","LU1251922891.USD","LU1255011170.USD","06618","BK1571","LU1993786604.SGD","LU0405327494.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146061353","title":"Junshi Bio appoints Chen Liang as Independent Non-Executive Director; committee leadership realigned","url":"https://stock-news.laohu8.com/highlight/detail?id=1146061353","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146061353?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:44","pubTimestamp":1782481477,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) confirmed that shareholders approved the election of Chen Liang as an Independent Non-Executive Director at the annual general meeting on 26 June...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173053017","title":"JUNSHI BIO Appoints Chen Liang as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1173053017","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173053017?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:12","pubTimestamp":1782479544,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (ASX: 01877) has announced that the resolution regarding the election of Mr. Chen Liang as an independent non-executive director was approved at the Annual General Meeting held on June 26,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115841086","title":"Junshi Bio Updates Board Composition and Committee Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1115841086","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115841086?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:04","pubTimestamp":1782479099,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026. The Board now consists of 14 members: seven executive directors,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107245560","title":"JUNSHI BIO Shares Surge Over 5% Following Strategic Investment in Shanghai Biopharma Firm for ADC and Multispecific Antibody Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1107245560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107245560?lang=en_us&edition=fundamental","pubTime":"2026-06-12 15:20","pubTimestamp":1781248859,"startTime":"0","endTime":"0","summary":"Shares of JUNSHI BIO (ASX: 01877) have risen more than 5%. At the time of writing, the stock is up 4.67% to HK$17.26, with a turnover of HK$65.60 million. Strategic Investment Announcement The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","01877","BK4231","BK4581","BK1583","161726","XBI","ADC","BK4585","BK4588","VXUS","BK4080","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107119","title":"Hong Kong Stocks Decline Amid Tech Selloff; Shanghai Junshi Biosciences Slips on Oncology Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107119","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641107119?lang=en_us&edition=fundamental","pubTime":"2026-06-08 16:48","pubTimestamp":1780908533,"startTime":"0","endTime":"0","summary":"Hong Kong stocks fell Monday as a technology-led selloff gathered pace after stronger-than-expected U.S. jobs data and renewed military tensions between Israel and Iran weighed on sentiment.The Hang Seng Index shed 1.2%, or 304.89 points, to close at 24,657.06, while the Hang Seng China Enterprises Index lost 1.1%, or 95.27 points, to finish at 8,341.36.The robust U.S. jobs report prompted traders to increase bets on a Federal Reserve rate hike later this year, triggering a selloff in technology stocks.Markets are now pricing in a 72% probability of a rate hike by December, according to CME Group's FedWatch tool.Meanwhile, Israel and Iran exchanged strikes for the first time since their ceasefire took effect, raising fresh doubts about the durability of the truce.The escalation came after U.S. President Donald Trump said Sunday that renewed military action by either side would not derail Washington's peace talks with Tehran.Brent crude rose more than $4 a barrel on Monday, extending ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["07500","BK1583","82800","83115","BK1161","02828","HHImain","HSI","HSTECH","BK1515","513600","07288","688180","03037","07588","03419","07300","02800","MCHmain","03115","03416","MHImain","07200","02833","82828","HSCEI","01877","09115"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641372103","title":"Junshi Biosciences Takes Stake in Oncology JV via Asset Contribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2641372103","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641372103?lang=en_us&edition=fundamental","pubTime":"2026-06-08 12:10","pubTimestamp":1780891840,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences (HKG:1877, SHA:688180) plans to contribute intellectual property, pre-clinical research assets, and related technology rights to a newly formed oncology-focused joint ventu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","01877","BK1515","BK0239","BK1161","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192267592","title":"JUNSHI BIO Tables AGM Agenda: No 2025 Dividend, Up to RMB8.50 Billion Credit, RMB5.00 Billion Guarantee Quota and Fresh Mandates for Debt and Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1192267592","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192267592?lang=en_us&edition=fundamental","pubTime":"2026-06-05 23:03","pubTimestamp":1780671815,"startTime":"0","endTime":"0","summary":"Shanghai-based biopharma developer JUNSHI BIO (01877) has released the circular for its 2025 Annual General Meeting to be held on 26 June 2026. Key proposals are summarised below: Financials &...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169733289","title":"Junshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election","url":"https://stock-news.laohu8.com/highlight/detail?id=1169733289","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169733289?lang=en_us&edition=fundamental","pubTime":"2026-06-05 23:03","pubTimestamp":1780671798,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) has released the proxy form for its 2025 Annual General Meeting, to be held on 26 June 2026 at 2:30 p.m. on the 15th Floor, Building 7, No. 6, Lane...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154186321","title":"Junshi BIO to Contribute Patent Equipment Valued at RMB 53.08 Million for Stake in Shanghai Zhiyu Biopharma, Expanding into ADC and Multi-Specific Antibody R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1154186321","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154186321?lang=en_us&edition=fundamental","pubTime":"2026-06-05 22:58","pubTimestamp":1780671524,"startTime":"0","endTime":"0","summary":"Junshi BIO (ASX: 01877) has announced its intention to enter into a joint venture agreement with Suzhou Zhonghe, Junshi Engineering, Suzhou Junmeng, the joint venture company Shanghai Zhiyu...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","XBI","BK4080","BK1515","BK4581","BK4585","BK4231","01877","BK1583","399441","161726","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181509895","title":"Junshi Bio Reorganises R&D Vehicle Junyan Hongshi; Controlled VC Arm Injects RMB0.10 Billion for 9.09% Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=1181509895","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181509895?lang=en_us&edition=fundamental","pubTime":"2026-06-05 22:22","pubTimestamp":1780669378,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) will introduce its controlled venture capital subsidiary, Ningbo Yongyuan Xinglun Junjin Venture Capital Investment Partnership, as a new...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139679490","title":"Junshi Bio to Close H-Share Register 23–26 June 2026 Ahead of 2025 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1139679490","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139679490?lang=en_us&edition=fundamental","pubTime":"2026-06-05 22:22","pubTimestamp":1780669377,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) will suspend the registration of its H-share transfers from Tuesday, 23 June 2026 through Friday, 26 June 2026, inclusive.       The temporary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":0.1111},{"period":"1month","weight":0.1058},{"period":"3month","weight":-0.2612},{"period":"6month","weight":-0.2647},{"period":"1year","weight":-0.2402},{"period":"ytd","weight":-0.1331}],"compareEarnings":[{"period":"1week","weight":0.0576},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0603},{"period":"6month","weight":-0.0775},{"period":"1year","weight":0.0021},{"period":"ytd","weight":-0.0558}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases. The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.105939},{"month":5,"riseRate":0.375,"avgChangeRate":-0.021039},{"month":6,"riseRate":0.375,"avgChangeRate":-0.04216},{"month":7,"riseRate":0.625,"avgChangeRate":0.001124},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"JUNSHI BIO","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JUNSHI BIO(01877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JUNSHI BIO,01877,JUNSHI BIO股票,JUNSHI BIO股票老虎,JUNSHI BIO股票老虎国际,JUNSHI BIO行情,JUNSHI BIO股票行情,JUNSHI BIO股价,JUNSHI BIO股市,JUNSHI BIO股票价格,JUNSHI BIO股票交易,JUNSHI BIO股票购买,JUNSHI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JUNSHI BIO(01877),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JUNSHI BIO(01877) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}